Pharma IQ Glossary: Biologics
Biologics includes a wide range of medicinal products such as vaccines, blood and blood components, allergenics, somatic cells, gene therapy, tissues, and recombinant therapeutic proteins created by biological processes. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living entities such as cells and tissues. Biologics are isolated from a variety of natural sources like human, animal, or microorganism and may be produced by biotechnology methods and other technologies.
A guide to manufacturing biologics
July 07 by Leila Hawkins
Pharma IQ explores the complexities of manufacturing biologics
Improving the Security, Quality & Compliance of your Biologic Operation
February 21 by Pharma IQIn the coming years, biologics are expected to make up a greater proportion of revenue growth for pharmaceutical companies, with some figures placing it as high as 60 per cent. The US Food...
Growing Number of Biologics Expand and Challenge Transportation Services
January 27 by Pharma IQThe market for biologics is expected to see significant growth in the foreseeable future. This follows a strong two years which saw the category contribute 17 percent of global pharmaceutical sales in...
Navigating the U.S. Department of Transportation’s Regulations for Biologics and Biological Agents
April 20 by Pharma IQPharma IQ chats with Eileen Edmonson, Pipeline and Hazardous Materials Safety Administration, U.S. Department of Transportation, about navigating the U.S. Department of Transportation’s regulations fo...
